Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease

Name: Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease
License: Public Domain

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metabolic dysfunction-associated steatotic liver disease, diabetes mellitus type 2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 146421
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.